SIC
ASTH icon

SJS Investment Consulting’s Astrana Health ASTH Stock Holding History

SJS Investment Consulting’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$311 – 1680
2025
Q1 		$311 Buy
10
+2
+25% +$67 ﹤0.01% 1373
2024
Q4 		$253 Sell
8
-1
-11% -$47 ﹤0.01% 1425
2024
Q3 		$522 Hold
9
– – ﹤0.01% 1312
2024
Q2 		$366 Buy
9
+5
+125% +$198 ﹤0.01% 1390
2024
Q1 		$168 Hold
4
– – ﹤0.01% 1514
2023
Q4 		$154 Buy
4
+2
+100% +$67 ﹤0.01% 1508
2023
Q3 		$62 Sell
2
-1
-33% -$35 ﹤0.01% 1580
2023
Q2 		$95 Hold
3
– – ﹤0.01% 1520
2023
Q1 		$110 Buy
3
+1
+50% +$35 ﹤0.01% 1452
2022
Q4 		$59 Buy
2
+1
+100% +$32 ﹤0.01% 1525
2022
Q3 		$0 Buy
+1
New +$46 ﹤0.01% 1618

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SJS Investment Consulting's ASTH Position: Q2 2025 in Review

SJS Investment Consulting sold out of Astrana Health (ASTH) in Q2 2025, closing a stake of 10 shares — an estimated $311 sold.

SJS Investment Consulting first reported a position in ASTH in Q3 2022 and held it in 11 quarters. The position peaked at $522 in Q3 2024. 162 funds tracked by Wall St. Rank hold ASTH as of Q2 2025.

  • SJS Investment Consulting reported no remaining Astrana Health position as of Q2 2025 after selling out during the quarter.
  • SJS Investment Consulting sold 10 Astrana Health shares in Q2 2025, an estimated $311.
  • SJS Investment Consulting first reported a position in Astrana Health in Q3 2022 and held it in 11 quarters.
  • SJS Investment Consulting's Astrana Health position peaked at $522 in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Astrana Health as of Q2 2025.

Based on SJS Investment Consulting's 13F filing for Q2 2025, filed 15 Jul 2025.